Performance Optimisation: Evidence-Backed Benefits and Realistic Expectations

Performance Optimization: Evidence-Backed Benefits and Realistic Expectations

The global sports and performance supplement market is projected to exceed $70 billion by 2030, yet the majority of products on shelves are dosed below clinical thresholds, built on proprietary blends that obscure what you're actually taking, and supported by marketing copy rather than peer-reviewed evidence. The result: most people cycling through pre-workouts, adaptogens, and nootropic stacks feel very little — not because the ingredients don't work, but because the doses are wrong, the timing is off, or the formula doesn't match their individual physiology.

This article cuts through the noise. We'll break down what performance optimization actually means across the domains of energy, cognition, physical output, and recovery — citing the studies that matter, the doses that were used, and the realistic timelines you should expect. Whether you're an athlete, an executive, or someone who simply wants to operate at their best, understanding the evidence is the first step toward building a stack that delivers.

What Does Performance Optimization Actually Mean?

Performance optimization is not a single outcome — it's a category that spans at least four distinct physiological domains:

1. Energy and mitochondrial output — the capacity to generate and sustain cellular energy (ATP) under load
2. Cognitive performance — working memory, processing speed, focus, and stress resilience
3. Physical output and recovery — strength, endurance, muscle repair, and inflammation management
4. Hormonal and adrenal regulation — cortisol balance, thyroid function, and the neuroendocrine substrate of drive and motivation

Each domain has distinct mechanisms, distinct ingredient targets, and distinct timelines. Treating "performance" as a single dial that supplements can simply turn up is why most stacks underperform. Precision matters — and precision requires knowing which system is the limiting factor for your individual biology.

Platforms like Ones approach this systematically: an AI health practitioner reviews your blood work, wearable data, and health history to identify which systems are genuinely underperforming, then builds a custom capsule formula from a catalog of ~70 clinically validated ingredients. The result is not a generic energy blend — it's a targeted intervention calibrated to your actual bottlenecks.

Evidence-Backed Ingredients for Energy and Mitochondrial Function

Cellular energy production is the foundation of every performance domain. Mitochondrial health — the efficiency with which your cells convert substrates into ATP — declines with age, chronic stress, poor sleep, and micronutrient insufficiency. Several ingredients have strong clinical evidence for supporting mitochondrial output.

CoQ10 (Ubiquinol, 200mg): Coenzyme Q10 is a critical electron carrier in the mitochondrial respiratory chain. In a 2014 randomized controlled trial of 420 patients with heart failure, CoQ10 supplementation at 300mg/day for two years significantly reduced major adverse cardiovascular events and improved functional capacity (Mortensen et al., JACC Heart Failure 2014; PMID: 25282031). For healthy adults, 200mg of ubiquinol — the reduced, more bioavailable form — is the dose most consistently associated with measurable improvements in fatigue and exercise tolerance. Ones includes ubiquinol at 200mg, matching the dosing range used in clinical fatigue research.

Magnesium Glycinate: Magnesium is a cofactor in over 300 enzymatic reactions, including ATP synthesis. A significant proportion of adults in the U.S. fall below the Estimated Average Requirement for magnesium (NIH Office of Dietary Supplements, 2022). The glycinate chelate form is associated with superior absorption and gastrointestinal tolerance compared to oxide or citrate forms. Low magnesium status has been independently associated with reduced exercise performance and elevated inflammatory markers (Zhang et al., Nutrients 2017; PMID: 28846654). You can explore optimal magnesium glycinate dosage for energy and sleep in more detail — the clinical case for this form is robust.

Omega-3 Fatty Acids (EPA/DHA): The anti-inflammatory effects of long-chain omega-3s are among the most replicated findings in nutritional science. For performance specifically, a meta-analysis of 18 RCTs found that omega-3 supplementation significantly reduced exercise-induced muscle soreness and markers of inflammation (Atashak et al., Journal of the International Society of Sports Nutrition 2021; doi.org/10.1186/s12970-021-00443-x). EPA and DHA also support neuronal membrane fluidity, which has downstream effects on cognitive speed and mood stability. The omega-3 EPA DHA ratio guide offers further context on dosing and sourcing.

Adaptogens and Stress Resilience: What the Clinical Trials Show

Adaptogen is a term that gets applied loosely — sometimes to ingredients with strong clinical evidence, sometimes to herbs backed by little more than tradition. Two adaptogens stand out from the noise with genuine, replicable human trial data.

Ashwagandha (KSM-66, 600mg/day): KSM-66 is a standardized root extract with the strongest evidence base among ashwagandha formulations. A double-blind, placebo-controlled trial in chronically stressed adults found that 600mg/day of KSM-66 significantly reduced serum cortisol, perceived stress scores, and self-reported anxiety after 60 days (Chandrasekhar et al., Indian Journal of Psychological Medicine 2012; PMID: 23439798). A separate 8-week RCT in resistance-trained men demonstrated significant improvements in muscle recovery, testosterone levels, and upper- and lower-body strength compared to placebo (Wankhede et al., Journal of the International Society of Sports Nutrition 2015; PMID: 26609282). The clinical evidence for ashwagandha goes deeper on the mechanistic and hormonal data. Ones includes KSM-66 at the full 600mg dose used in both trials.

Rhodiola Rosea: Rhodiola has a well-characterized mechanism: it modulates the stress-response pathway via monoamine oxidase inhibition and influences the HPA axis. A randomized trial of 56 physicians found that Rhodiola rosea extract (170mg/day) significantly reduced fatigue and improved cognitive performance on night shifts compared to placebo (Darbinyan et al., Phytomedicine 2000; PMID: 11081987). More recent work has confirmed its role in reducing burnout-associated exhaustion (Lekomtseva et al., Neuropsychiatric Disease and Treatment 2017; PMID: 28293161). For high-demand cognitive performers, Rhodiola is among the most well-supported options in the adaptogen category.

Vitamin D3 and K2: The Underrated Performance Stack

Vitamin D deficiency is extraordinarily common among adults in the northern hemisphere and among people who work predominantly indoors — and its performance implications are significant. Vitamin D receptors are present in skeletal muscle, and deficiency has been associated with reduced muscle strength, increased injury risk, and impaired immune function (Holick et al., Journal of Clinical Endocrinology & Metabolism 2011; PMID: 21154195).

The synergy between D3 and K2 (as MK-7) is now well-recognized: vitamin D3 increases calcium absorption, while K2 directs that calcium into bone matrix rather than arterial walls, reducing calcification risk (Kidd, Alternative Medicine Review 2010; PMID: 20568258). For performance athletes and older adults, this combination supports the skeletal and cardiovascular infrastructure that underpins physical output. The vitamin D3 and K2 synergy article provides detailed guidance on testing and optimal target levels.

Realistic Timelines: When to Expect Results

One of the most common points of confusion in performance supplementation is timeline. Many people abandon protocols after two weeks because they haven't felt a dramatic shift. Evidence-based expectation management:

1. Days 1–7: Some ingredients with acute mechanisms — like Rhodiola and caffeine — may produce perceptible effects within the first week, particularly on subjective energy and mental clarity.
2. Weeks 2–4: Adaptogenic effects from ashwagandha begin to accumulate; magnesium repletion, if you were deficient, typically shows improvements in sleep quality and mood within this window.
3. Weeks 6–12: Structural changes — improved VO2 max, measurable cortisol reduction, increased muscle protein synthesis with CoQ10 and omega-3 — typically require 8–12 weeks of consistent use at clinical doses.
4. Months 3–6: Vitamin D status normalization, longer-term hormonal rebalancing, and sustained mitochondrial adaptations play out over this horizon.

The takeaway: performance optimization is not a single-dose intervention. It is a sustained physiological investment, and the returns compound over time when the inputs are correct.

How Ones Addresses This

Generic performance stacks fail for a predictable reason: they assume everyone has the same bottlenecks. An executive with elevated cortisol and sleep debt needs a different formula than an endurance athlete with low ferritin and borderline vitamin D. Ones is built around this core insight.

After analyzing your blood work and wearable data, the Ones AI health practitioner identifies which performance domains are genuinely constrained — and builds a custom capsule formula to address them specifically. Three ingredients illustrate how Ones operationalizes the clinical evidence:

• KSM-66 Ashwagandha at 600mg: Included when cortisol patterns, HRV data, or self-reported stress indicate HPA axis dysregulation. This is the exact dose used in the Chandrasekhar 2012 trial showing 27.9% cortisol reduction over 60 days.
• CoQ10/Ubiquinol at 200mg: Prioritized for users with fatigue, statin use (which depletes endogenous CoQ10), or wearable data showing poor sleep quality and recovery scores — all contexts where mitochondrial support has documented clinical benefit.
• Adrenal Support System Blend: A proprietary blend designed for users whose data points to chronic stress-mediated fatigue. Rather than a single adaptogen, it combines multiple evidence-supported ingredients calibrated to work synergistically — addressing the adrenal-cortisol axis as a system rather than a single variable.

Formulas are built in 6, 9, or 12-capsule configurations depending on the number of targeted systems, and every ingredient is dosed to the clinical ranges used in the human trials that substantiate its inclusion. Nothing is dosed for label impressiveness — everything is dosed to work.

Key Takeaways

• Performance optimization spans four domains — energy, cognition, physical output, and hormonal regulation — and each requires distinct ingredient targets and timelines.
• Clinical dosing is non-negotiable: KSM-66 at 600mg, CoQ10 at 200mg, and Omega-3 at 2–3g/day are the thresholds at which human trials demonstrate meaningful effects; sub-clinical doses produce sub-clinical results.
• Adaptogens have real, replicable evidence — KSM-66 and Rhodiola Rosea both have multiple RCTs showing cortisol reduction, fatigue resistance, and cognitive benefit, but only at the doses and durations used in those trials.
• Results require patience: acute effects emerge in days, adaptogenic benefits in 4–8 weeks, and structural physiological changes in 8–12+ weeks — consistency at clinical doses is what separates effective supplementation from expensive placebo.
• Personalization outperforms generic stacks: individual blood work, wearable data, and health history reveal which systems are the actual limiting factor — a targeted formula addresses real bottlenecks, not assumed ones.
• Consult a healthcare provider before beginning any new supplementation protocol, particularly if you have existing medical conditions, take prescription medications, or have abnormal lab values that require clinical management.